A phase II study of the continuous intravenous infusion of interleukin-6 for metastatic renal cell carcinoma

J Immunother Emphasis Tumor Immunol. 1995 Jul;18(1):52-6. doi: 10.1097/00002371-199507000-00007.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Renal Cell / complications
  • Carcinoma, Renal Cell / therapy*
  • Drug Administration Schedule
  • Female
  • Humans
  • Infusions, Intravenous
  • Interleukin-6 / administration & dosage*
  • Interleukin-6 / adverse effects
  • Interleukin-6 / therapeutic use*
  • Kidney Neoplasms / complications
  • Kidney Neoplasms / therapy*
  • Lung Neoplasms / secondary
  • Lung Neoplasms / therapy
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Soft Tissue Neoplasms / secondary
  • Soft Tissue Neoplasms / therapy

Substances

  • Interleukin-6